Switch Study of Existing Atypical Antipsychotics to Bifeprunox

Clinical trial NCT00347425 · COMPLETED

Trial details

NCT number: NCT00347425
Sponsor: Solvay Pharmaceuticals
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Schizophrenia and Schizoaffective Disorder

Start date: 2006-12-01
Primary completion: 2008-02-01
Enrollment: 286

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.